Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin cervical and vaginal pharmacokinetics in women with genital chlamydia infection
ACTRN12616001684415Phase 4Completed
- Sponsor
- University of Melbourne
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of azithromycin in Chlamydia trachomatis infection, sponsored by University of Melbourne. Primary endpoint: Vaginal tissue concentrations of azithromycin. Started Jul 2012; status: completed.
02
Drugs
azithromycin
03
Conditions
Chlamydia trachomatis infection
Beyond the preview
Go deeper on ACTRN12616001684415.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616001684415.